0001104659-23-035224.txt : 20230321
0001104659-23-035224.hdr.sgml : 20230321
20230321193259
ACCESSION NUMBER: 0001104659-23-035224
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230321
DATE AS OF CHANGE: 20230321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Kimberly Ann
CENTRAL INDEX KEY: 0001965590
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40598
FILM NUMBER: 23750938
MAIL ADDRESS:
STREET 1: C/O ZURA BIO INC.
STREET 2: 4225 EXECUTIVE SQUARE, SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zura Bio Ltd
CENTRAL INDEX KEY: 0001855644
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-247-0520
MAIL ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: JATT Acquisition Corp
DATE OF NAME CHANGE: 20210407
3
1
tm2310127-1_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2023-03-20
0
0001855644
Zura Bio Ltd
ZURA
0001965590
Davis Kimberly Ann
4225 EXECUTIVE SQUARE,
SUITE 600
LA JOLLA
CA
92037
0
1
0
0
Secretary and General Counsel
Employee Share Option (Right to Buy)
1.20
2033-03-15
Class A Ordinary Shares
206547
D
The Reporting Person was granted the option on March 15, 2023. 25% of the shares underlying the option vest one year after the grant date, then the remaining shares vest in monthly installments of 2.083% thereafter starting on the last day of the following full month until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
In connection with the closing of the business combination between the Issuer and Zura Bio Limited, a company incorporated under the laws of England and Wales ("Zura"), among other things, each ordinary share of Zura was exchanged pursuant to the terms of the Business Combination Agreement (including the corporate restructuring of Zura contemplated therein) into Class A Ordinary Shares of the Issuer (the exchange ratio used for such exchange is hereinafter referred to as the "Exchange Ratio"). In addition, each outstanding Zura equity award was automatically converted into a corresponding equity award of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Zura equity awards.
/s/ Kimberly Ann Davis
2023-03-21